American Journal of Cardiology
Volume 101, Issue 8, Supplement , Pages S27-S35 , 17 April 2008

Reducing the Residual Risk of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy With Combination Therapy

  • Tamar S. Polonsky, MD
    • ,
  • Michael H. Davidson, MD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Michael H. Davidson, MD, University of Chicago, Pritzker School of Medicine, 5758 South Maryland Avenue, MC 9024, Chicago, Illinois 60637-1470.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9149(08)00367-6

doi: 10.1016/j.amjcard.2008.02.051

American Journal of Cardiology
Volume 101, Issue 8, Supplement , Pages S27-S35 , 17 April 2008

Article Tools

* Image Usage & Resolution